Paul Hastings LLP advised J.P. Morgan Securities LLC as the exclusive placement agent in the transaction. Leap Therapeutics, Inc. (Nasdaq:LPTX) has entered into a securities purchase agreement with...
Leap Therapeutics’ $40 Million Private Placement
Century Therapeutics’ $60 Million Private Placement
Paul Hastings LLP advised BofA Securities as the sole placement agent in the transaction. Century entered into a securities purchase agreement with a select group of...
Global Business Travel Group’s $570 Million Acquisition of CWT US
Paul Hastings LLP advised CWT US, LLC in the transaction. Global Business Travel Group, Inc. signed the agreement to acquire CWT US, LLC, a transaction valued at $570...
H.I.G. Capital’s Acquisition of Segers
Paul Hastings advised H.I.G. Capital, while Sheppard Mullin advised Segers on the deal. H.I.G. Capital, a global alternative investment firm with $60 billion of capital under...
Fort Partners’ Redevelopment of 15th Century Palace Near Vatican into Four Seasons Hotel
Paul Hastings LLP advised affiliates of Fort Partners on the matter. Fort Partners announced the redevelopment of Palazzo della Rovere, a 15th century palace near the Vatican,...
Marc-Henry Cruise Holdings’ Venture with Four Seasons for the Creation of Four Seasons Yachts
Paul Hastings LLP advised Marc-Henry Cruise Holdings in the transaction. Marc-Henry Cruise Holdings LTD announced a multi-billion dollar venture with Four Seasons for the creation of...
Telamon’s Capital Reorganization
Paul Hastings (Europe) LLP advised Andera Partners on the transaction. Andera Partners (Winch Capital 4 fund) announced the capital reorganization of Telamon, resulting in a capital...
Gresham Technologies’ Take-Private Transaction
Taylor Wessing advised Gresham Technologies, while Paul Hastings (Europe) LLP advised STG Partners, LLC and Alliance Bidco on the deal. STG Partners, LLC (“STG”), a private...
Stryker’s Acquisition of Serf
Paul Hastings (Europe), August Debouzy and Lamartine Conseil advised Menix in the transaction, while DLA Piper advised Stryker on the transaction. Stryker, one of the world’s...
Pemberton’s €2.3 Billion Closing of Credit Fund III
Paul Hastings (Europe) LLP advised Pemberton Asset Management and Elvinger Hoss Prussen advised on the Luxembourg law aspects of the fund. Pemberton Asset Management, one of...
NervGen’s C$23 Million Bought Deal Financing
Paul Hastings LLP advised NervGen Pharma Corp. in the transaction. NervGen Pharma Corp. closed its public offering including the full exercise of the underwriters’ over-allotment option...
Pemberton’s Launch of ELTIF 2.0 Private Credit Fund
Paul Hastings (Europe) LLP advised Pemberton Asset Management on the deal. Pemberton Asset Management (“Pemberton”), one of Europe’s leading private credit managers, announced the launch of...